ClinicalTrials.Veeva

Menu

A New Approach to a Personalized Patient Blood Management Program (pPBM) in Total Hip Arthroplasty (THA)

K

Krankenhaus der Barmherzigen Brüder Trier

Status

Completed

Conditions

Postoperative Anemia

Study type

Observational

Funder types

Other

Identifiers

NCT02519088
KrankenhausBBT

Details and patient eligibility

About

The study evaluates the patient related risk and predictive factors concerning perioperative homologous blood cell transfusion (erythrocyte concentrate ) in THA patients in one EndoCert max-certified orthopedic hospital in Germany.

A patient oriented preoperative decision-making algorithm (a personalised Patient Blood Management or pPBM App) will be developed as a new patient-safety blood-sparing strategy.

The aim is to increase the patient safety by using the pPBM App and to reach a more efficient management of resources.

Full description

Retrospective audit of 470 consecutive primary THA in 2013 and 2014

Enrollment

477 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • primary THA on patients with coxarthrosis

Exclusion criteria

  • any kind of old or acute fractures about the basin and hip
  • combined surgery, like first extracting a femur nail and than undergoing THA
  • any other kind of combined or simultaneous surgery
  • any kind of coagulopathy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems